Huaxia Eye Hospital Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	3,979	3,922	3,774	3,745	3,130	3,007
Other Revenue	217.37	217.37	253.24	268.34	103.09	57.77
Revenue	4,196	4,139	4,027	4,013	3,233	3,064
Revenue Growth (YoY)	1.31%	2.79%	0.34%	24.12%	5.51%	21.86%
Cost of Revenue	2,374	2,356	2,259	2,055	1,687	1,661
Gross Profit	1,822	1,783	1,768	1,958	1,546	1,403
Selling, General & Admin	1,102	1,086	1,077	986.7	758.43	712.2
Research & Development	61.14	61.44	70.63	69.68	49.27	25.2
Other Operating Expenses	21.33	15.02	13.66	11.89	10.82	12.43
Operating Expenses	1,189	1,168	1,173	1,080	822.02	754.19
Operating Income	633.21	615.23	594.57	878.8	724.3	649.04
Interest Expense	-46.72	-46.96	-45.13	-38.04	-38.36	-37.61
Interest & Investment Income	42.83	52.22	87.6	99.96	19.2	10.47
Other Non Operating Income (Expenses)	0.91	-7.89	-86.73	-124.11	-78.25	-5.97
EBT Excluding Unusual Items	630.22	612.6	550.31	816.61	626.88	615.93
Impairment of Goodwill	-6.19	-6.19	-11.24	-4.64	-	-
Gain (Loss) on Sale of Investments	-8.64	-9.29	-5.09	11.02	6.51	-
Gain (Loss) on Sale of Assets	6.67	2.46	3.49	11.28	1.85	0.1
Asset Writedown	-1.42	-1.42	-0.79	-1.51	-0.46	-1.88
Other Unusual Items	-22.07	-24.35	26.49	21.55	18.83	-31.82
Pretax Income	598.57	573.81	563.17	854.31	653.61	582.33
Income Tax Expense	146.56	140.76	134.95	176.89	144.41	128.7
Earnings From Continuing Operations	452.01	433.06	428.22	677.42	509.2	453.63
Net Income to Company	452.01	433.06	428.22	677.42	509.2	453.63
Minority Interest in Earnings	10.63	7.6	0.43	-11.49	4.62	1.29
Net Income	462.64	440.65	428.64	665.93	513.82	454.92
Net Income to Common	462.64	440.65	428.64	665.93	513.82	454.92
Net Income Growth	9.53%	2.80%	-35.63%	29.60%	12.95%	36.01%
Shares Outstanding (Basic)	838	831	840	843	767	750
Shares Outstanding (Diluted)	838	831	840	843	767	750
Shares Change (YoY)	-0.60%	-1.08%	-0.29%	9.92%	2.28%	0.14%
EPS (Basic)	0.55	0.53	0.51	0.79	0.67	0.61
EPS (Diluted)	0.55	0.53	0.51	0.79	0.67	0.61
EPS Growth	10.19%	3.92%	-35.44%	17.91%	10.43%	35.82%
Free Cash Flow	737.73	635.59	540.71	512.81	534.68	624.38
Free Cash Flow Per Share	0.88	0.76	0.64	0.61	0.70	0.83
Dividend Per Share	0.260	0.260	0.220	0.110	0.187	-
Dividend Growth	18.18%	18.18%	100.00%	-41.08%	-	-
Gross Margin	43.41%	43.07%	43.90%	48.80%	47.83%	45.79%
Operating Margin	15.09%	14.86%	14.77%	21.90%	22.40%	21.18%
Profit Margin	11.03%	10.65%	10.64%	16.59%	15.89%	14.85%
Free Cash Flow Margin	17.58%	15.36%	13.43%	12.78%	16.54%	20.38%
EBITDA	798.58	781.48	764.3	1,028	878.91	803.7
EBITDA Margin	19.03%	18.88%	18.98%	25.60%	27.18%	26.23%
D&A For EBITDA	165.38	166.25	169.73	148.75	154.61	154.66
EBIT	633.21	615.23	594.57	878.8	724.3	649.04
EBIT Margin	15.09%	14.86%	14.77%	21.90%	22.40%	21.18%
Effective Tax Rate	24.48%	24.53%	23.96%	20.71%	22.10%	22.10%
Revenue as Reported	4,196	4,139	4,027	4,013	3,233	3,064
Advertising Expenses	-	271.14	273.11	259.35	147.9	129.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.